Cargando…
含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957243/ https://www.ncbi.nlm.nih.gov/pubmed/33677875 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.01.016 |
| _version_ | 1783664612235804672 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7957243 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79572432021-03-15 含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2021-01 /pmc/articles/PMC7957243/ /pubmed/33677875 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.01.016 Text en 2021年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
| spellingShingle | 病例报告 含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例 |
| title | 含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例 |
| title_full | 含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例 |
| title_fullStr | 含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例 |
| title_full_unstemmed | 含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例 |
| title_short | 含达雷妥尤单抗联合方案挽救治疗早期前体T淋巴母细胞白血病一例 |
| title_sort | 含达雷妥尤单抗联合方案挽救治疗早期前体t淋巴母细胞白血病一例 |
| topic | 病例报告 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957243/ https://www.ncbi.nlm.nih.gov/pubmed/33677875 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.01.016 |
| work_keys_str_mv | AT hándáléituǒyóudānkàngliánhéfāngànwǎnjiùzhìliáozǎoqīqiántǐtlínbāmǔxìbāobáixuèbìngyīlì AT hándáléituǒyóudānkàngliánhéfāngànwǎnjiùzhìliáozǎoqīqiántǐtlínbāmǔxìbāobáixuèbìngyīlì AT hándáléituǒyóudānkàngliánhéfāngànwǎnjiùzhìliáozǎoqīqiántǐtlínbāmǔxìbāobáixuèbìngyīlì AT hándáléituǒyóudānkàngliánhéfāngànwǎnjiùzhìliáozǎoqīqiántǐtlínbāmǔxìbāobáixuèbìngyīlì AT hándáléituǒyóudānkàngliánhéfāngànwǎnjiùzhìliáozǎoqīqiántǐtlínbāmǔxìbāobáixuèbìngyīlì AT hándáléituǒyóudānkàngliánhéfāngànwǎnjiùzhìliáozǎoqīqiántǐtlínbāmǔxìbāobáixuèbìngyīlì |